Delivery Order SPE2DR25D3301-SPE2DR26F20RS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,471.53 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count) with a completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on October 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $8,189.46 delivery order to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count) with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 16, 2025. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $6,774.81 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and active through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $5,608.49 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 50 mg capsules (30-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This non-set-aside, competitively awarded contract operates under a firm fixed-price structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a contract ceiling value of $8,032.67. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $35,031.13 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Topiramate ER 100 mg capsules. This order was placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.18 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count units) on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed price, non-set-aside contract for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs....
- The Defense Logistics Agency awarded a delivery order valued at $6,195.98 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $1,438.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,060.67 to AmerisourceBergen Drug Corp for the supply of Topiramate 100 mg tablets (1,000 count) under a firm fixed price contract type. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20RSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,244.58 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count units), with an ultimate completion date of January 14, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's Conshohocken, Pennsylvania location. The delivery order was competitively awarded and falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 prime contract vehicle designated SPE2DX that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor providing critical medical supplies to federal agencies, particularly the Department of Defense and military healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order represents routine pharmaceutical procurement activity supporting the Defense Health Agency and related military medical treatment facilities, consistent with the company's established role as a primary vendor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/12/26 |